Recruiting COVID-19 Studies in Columbus
NE3107 in Adults With Neurological Symptoms of Long COVID
Long COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluate the effects of NE3107 on several neurological symptoms reported in ...
SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease
The 2019 Severe Acute Respiratory Syndrome (SARS) is a global pandemic secondary to a novel coronavirus - SARS-CoV-2. The reported case-fatality ratio for SARS-CoV-2 in the United States is 1.8% with ...
About COVID-19 Clinical Trials in Columbus
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus that primarily affects the respiratory system. Long COVID (PASC) involves persistent symptoms weeks or months after initial infection. Treatment includes antiviral medications, monoclonal antibodies, and supportive care.
There are currently 2 covid-19 clinical trials recruiting participants in Columbus, IN. These studies are seeking a combined 258 participants. Research is being sponsored by BioVie Inc., New York Medical College. Clinical trial participation is free and participants receive study-related medical care at no cost.
COVID-19 Clinical Trials in Columbus — FAQ
Are there covid-19 clinical trials in Columbus?
Yes, there are 2 covid-19 clinical trials currently recruiting in Columbus, IN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Columbus?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbus research site will contact you about next steps.
Are clinical trials in Columbus free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbus studies also compensate for your time and travel.
What covid-19 treatments are being tested?
The 2 active trials in Columbus are testing new therapies including novel drugs, biologics, and treatment approaches for covid-19.
Data updated March 2, 2026 from ClinicalTrials.gov